Converge Biotech, Inc. — Form D/A
Converge Biotech, Inc. of MIAMI, FL, a company, filed a Form D amendment with the SEC on 2013-07-12. The offering totals $1.0M. Industry: Biotechnology.
Offering
- Filed: 2013-07-12
- Form: D/A
- Accession: 0001579833-13-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Remaining: $1.0M
- Minimum investment: $50K
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-199358
Issuer
- Name: Converge Biotech, Inc.
- CIK: 0001579833
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1450 NW 10TH AVE., MIAMI, FL, 33136
- Phone: 305-243-1913
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Paul Latta | Director | Belleuve, WA |
| Paul Latta | Executive Officer | Belleuve, WA |
| Paul Latta | Promoter | Belleuve, WA |
Other filings by this issuer (1)
More